2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4377):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W106164A
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol
    		99.40%
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol is a drug intermediate for synthesis of various active compounds.
    ((2S,7aS)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol
  • HY-W110319
    o-Tolidine Sulfone(contains 2,6-Dimethyl isomer)
    		99.70%
    o-Tolidine Sulfone(contains 2,6-Dimethyl isomer) (3,7-Diamino-2,8-dimethyldibenzothiophene sulfone(contains 2,6-Dimethyl isomer)) is a drug intermediate for synthesis of various active compounds.
    o-Tolidine Sulfone(contains 2,6-Dimethyl isomer)
  • HY-Y0925
    5-Hexynoic acid
    5-Hexynoic acid (Hex-5-ynoic acid) is an alkynoic acid. 5-Hexynoic acid serves as a drug intermediate for the synthesis of 3-alkoxy-2-cyclohexenone.
    5-Hexynoic acid
  • HY-20007
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine
    		99.78%
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine is a drug intermediate for synthesis of various active compounds.
    2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine
  • HY-W008147
    3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
    		99.66%
    3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a drug intermediate for synthesis of various active compounds.
    3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
  • HY-77016
    Ethyl 5-aminobenzofuran-2-carboxylate
    		99.81%
    Ethyl 5-aminobenzofuran-2-carboxylate (Vilazodone Intermediate 5) is a drug intermediate for synthesis of various active compounds.
    Ethyl 5-aminobenzofuran-2-carboxylate
  • HY-34485
    tert-Butyl (1R,5S)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
    		99.98%
    tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylate is a pharmaceutical intermediate containing a dinitrogen-bridged ring structure, used in the synthesis of various active compounds.
    tert-Butyl (1R,5S)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
  • HY-W041989
    Fmoc-Oic-OH
    		99.86%
    Fmoc-Oic-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize bioactive peptide mimetics, such as [desArg10]HOE 140, which has bradykinin B1 antagonist activity.
    Fmoc-Oic-OH
  • HY-40249
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester
    		99.82%
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester is a drug intermediate that can be used for the preparation of SMARCA bromodomain ligands.
    1-Boc-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester
  • HY-W390763B
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride
    		99.77%
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride is a drug intermediate for synthesis of various active compounds.
    (S)-6-Methyl-1,4-oxazepan-6-ol hydrochloride
  • HY-W153871
    5-Bromo-6-nitro-1,3-benzodioxole
    		99.53%
    5-Bromo-6-nitro-1,3-benzodioxole is a drug intermediate for synthesis of various active compounds.
    5-Bromo-6-nitro-1,3-benzodioxole
  • HY-W020014
    Pyruvic aldehyde (40%w/w in water)
    Pyruvic aldehyde (40%w/w in water) is a cell stabilizer. Pyruvic aldehyde (40%w/w in water) can be used for stabilization of cells, such as erythrocytes. Pyruvic aldehyde (40%w/w in water) can be efficiently catalyzed to Lactic acid (HY-B2227) by a Lewis acid catalyst.
    Pyruvic aldehyde (40%w/w in water)
  • HY-77001
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
    		99.99%
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid is a drug intermediate for synthesis of various active compounds.
    5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
  • HY-78334
    4-Aminobenzo-12-crown-4
    		98.0%
    4-Aminobenzo-12-crown-4 is a drug intermediate for synthesis of various active compounds.
    4-Aminobenzo-12-crown-4
  • HY-41599
    2-Formylphenoxyacetic acid
    		99.45%
    2-Formylphenoxyacetic acid (2-Carboxymethoxybenzaldehyde) is a drug intermediate for synthesis of various active compounds.
    2-Formylphenoxyacetic acid
  • HY-120947
    AV-105
    		99.70%
    AV-105 is a Florbetapir (18F)-radiolabeled slyrylpyridine tosylate precursor extracted from patent WO2010078370A1, example 1.5. AV-105 can synthesize 18F-radiolabeled compounds, which are used for positron emission tomography (PET) imaging of neurodegenerative diseases of the brain.
    AV-105
  • HY-59137
    1-Methylimidazole
    		99.99%
    1-Methylimidazole acts as a membrane performance regulator that promotes the formation of reverse osmosis membranes with a dense ultra-thin polyamide layer. Such membranes exhibit higher flux and salt rejection rate, while also conferring excellent pH stability to the membrane. 1-Methylimidazole can serve as a ligand for ruthenium (II) complexes to construct metal-based anticancer agents.
    1-Methylimidazole
  • HY-76039
    3-(3-Trifluoromethylphenyl)propanol
    		99.98%
    3-(3-Trifluoromethylphenyl)propanol is a drug intermediate for synthesis of various active compounds.
    3-(3-Trifluoromethylphenyl)propanol
  • HY-W095670
    2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine
    		99.95%
    2,4,7-Trichloro-8-fluoropyridopyrimidine is a pyridopyrimidine synthetic intermediate of MRTX1133 (HY-134813), which can be used for the synthesis of non-covalent KRASG12D inhibitors.
    2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine
  • HY-W024615
    Me-diazirine-cooh
    		98.0%
    Me-diazirine-cooh (3-(3-Methyl-3H-diazirin-3-yl) propanoic acid) is a molecular building block containing an aliphatic diazirine ring. Me-diazirine-cooh undergoes orthogonal coupling in solid-phase peptide synthesis to introduce the Diazirine group into collagen-mimetic peptides. Me-diazirine-cooh is used to construct the photoaffinity probe P1.
    Me-diazirine-cooh